American International Group, Inc. Imago Bio Sciences, Inc. Transaction History

American International Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$15.03 - $35.96 $676 - $1,618	-45 Reduced 0.36%	12,447 $447,000
Q3 2022 Nov 14, 2022	BUY	$14.15 - $19.5 $2,490 - $3,432	176 Added 1.43%	12,492 $188,000
Q2 2022 Aug 12, 2022	BUY	$11.81 - $20.92 $27,777 - $49,203	2,352 Added 23.6%	12,316 $165,000
Q1 2022 May 13, 2022	BUY	$16.97 - $25.0 $81,150 - $119,550	4,782 Added 92.28%	9,964 $192,000
Q4 2021 Feb 11, 2022	SELL	$16.22 - $29.69 $2,497 - $4,572	-154 Reduced 2.89%	5,182 $123,000
Q3 2021 Nov 12, 2021	BUY	$16.0 - $28.84 $85,376 - $153,890	5,336 New	5,336 $107,000

19.3K

Ticker IMGO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,741,600
Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.